Literature DB >> 19481038

Feline rabies. ABCD guidelines on prevention and management.

Tadeusz Frymus1, Diane Addie, Sándor Belák, Corine Boucraut-Baralon, Herman Egberink, Tim Gruffydd-Jones, Katrin Hartmann, Margaret J Hosie, Albert Lloret, Hans Lutz, Fulvio Marsilio, Maria Grazia Pennisi, Alan D Radford, Etienne Thiry, Uwe Truyen, Marian C Horzinek.   

Abstract

OVERVIEW: Rabies virus belongs to the genus Lyssavirus, together with European bat lyssaviruses 1 and 2. In clinical practice, rabies virus is easily inactivated by detergent-based disinfectants. INFECTION: Rabid animals are the only source of infection. Virus is shed in the saliva some days before the onset of clinical signs and transmitted through a bite or a scratch to the skin or mucous membranes. The average incubation period in cats is 2 months, but may vary from 2 weeks to several months, or even years. DISEASE SIGNS: Any unexplained aggressive behaviour or sudden behavioural change in cats must be considered suspicious. Two disease manifestations have been identified in cats: the furious and the dumb form. Death occurs after a clinical course of 1-10 days. DIAGNOSIS: A definitive rabies diagnosis is obtained by post-mortem laboratory investigation. However, serological tests are used for post-vaccinal control, especially in the context of international movements. DISEASE MANAGEMENT: Post-exposure vaccination of cats depends on the national public health regulations, and is forbidden in many countries. VACCINATION RECOMMENDATIONS: A single rabies vaccination induces a long-lasting immunity. Kittens should be vaccinated at 12-16 weeks of age to avoid interference from maternally derived antibodies and revaccinated 1 year later. Although some vaccines protect against virulent rabies virus challenge for 3 years or more, national or local legislation may call for annual boosters.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19481038     DOI: 10.1016/j.jfms.2009.05.007

Source DB:  PubMed          Journal:  J Feline Med Surg        ISSN: 1098-612X            Impact factor:   2.015


  4 in total

1.  Neutralizing antibody response in dogs and cats inoculated with commercial inactivated rabies vaccines.

Authors:  Rikiya Shiraishi; Masaaki Nishimura; Ryuji Nakashima; Chiho Enta; Norio Hirayama
Journal:  J Vet Med Sci       Date:  2013-12-31       Impact factor: 1.267

2.  Bat rabies surveillance and risk factors for rabies spillover in an urban area of Southern Brazil.

Authors:  Juliano Ribeiro; Claudia Staudacher; Camila Marinelli Martins; Leila Sabrina Ullmann; Fernando Ferreira; João Pessoa Araujo; Alexander Welker Biondo
Journal:  BMC Vet Res       Date:  2018-06-01       Impact factor: 2.741

Review 3.  Feline blood transfusions: A pinker shade of pale.

Authors:  Dominic Barfield; Sophie Adamantos
Journal:  J Feline Med Surg       Date:  2011-01       Impact factor: 2.015

Review 4.  Vaccination and Antibody Testing in Cats.

Authors:  Herman Egberink; Tadeusz Frymus; Katrin Hartmann; Karin Möstl; Diane D Addie; Sándor Belák; Corine Boucraut-Baralon; Regina Hofmann-Lehmann; Albert Lloret; Fulvio Marsilio; Maria Grazia Pennisi; Séverine Tasker; Etienne Thiry; Uwe Truyen; Margaret J Hosie
Journal:  Viruses       Date:  2022-07-22       Impact factor: 5.818

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.